San Jose, California (PRWEB) September 17, 2013
Follow us on LinkedIn – In the coming months, GIA will complete an extensive secondary and primary research program involving some of the industry’s leading players and experts. The study will examine key drivers and trends impacting the market such as innovative developments in functional biocomposite materials; impact of the role played by nanotechnology in the development of new implant materials; steady migration away from passive, bioinert implants to bioactive implants that encourage cell growth and regeneration; increased R&D focus on engineered stem cell implants; aging population and increased demand for orthopaedic and dental implants.
Also known as biological implants, Bio-Implants are defined as medical devices manufactured from biocompatible materials as substitute or replacement for damaged biological structures. Manufacturing of medical implants is undergoing rapid change supported by developments in material science and evolving medical needs. Rising focus on curtailing spiralling healthcare costs is creating significant interest in the development of implants with antibacterial, corrosion resistant and bioactive features. In the field of orthopaedics, for instance, the need for repeat surgeries for replacements of implants is still as high as 15%. Repeated surgeries tend to result in fibrotic changes in tissues and muscles leading to postoperative infection, trauma, and scarring. This in turn extends hospitalization period and healthcare costs. Poised to benefit under this scenario are bio-plants with longer life, improved surface porosity for superior cell response, and higher structural strength.
Growing preference for non-invasive medical procedures especially among the elderly with lower ability to tolerate surgical trauma, is creating robust demand for Non-Surgical Bio-Implants. Injectable bio-implants in this regard are forecast to grow in popularity. Cosmetic and aesthetic surgeries present opportunities for growth in this space. Stem cell based breast implants for instance, are increasingly replacing the use of breast implant devices. Another promising application area is engineered stem cell implants in the treatment of cardiac dyssynchrony. Research studies indicate higher effectiveness of stem cell-based 'biological resynchronization' of cardiac motions as compared to device-based resynchronization.
Developments in Nanobiotechnology is forecast to benefit the market in the coming years by helping catalyse the development of high strength structures and materials with superior biocompatibility features such as cell adhesion and osteoinduction. The future is likely to witness the launch of bio-implants capable of releasing active biological substances that reduce the risk of implant rejections, infections, and inflammatory reactions. Cardiovascular, Spinal, Orthopaedic, Dental, Ophthalmic, and Neurostimulator implants are all forecast to witness strong growth in the global bio-implants market.
The study estimates the global Bio-Implants market to be a multi-million dollar market, while more precise market-size and growth projections for a 14-year period will be made available during the 2nd stage of report preparation, and data analysis.
The research and analyses will be released shortly in the form of a comprehensive research report. The report by design, will attempt to provide exhaustive analysis, data, trends, market share, market size, statistics, forecasts and competitive intelligence. The report is modeled to offer precise and unbiased, actionable market insights including in-depth segmentation of market sub-sectors, demand estimates and projections and analysis of trends in each of the sectors, identification of leading players, and the competitive structure, among others.
Developed for Medical Device Manufacturers, Strategic Planners, Business Development Executives, Management Consultants, Investment Bankers, Consulting Firms, Marketing & Sales Executives, C-Level Decision Makers, Market Strategists and Technology Domain Experts, the report helps identify the biggest opportunities in this space and offers accurate latent demand forecasting that empowers quantitative decision making among existing market players and new entrants.
For more details about how you can participate, please click here
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/